References
Takeuchi M, Yano T, Omoto E. Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with alltrans retinoic acid. British Journal of Haematology 97: 137–140, No. 1, Apr 1997
Tobita T, Takeshita A, Kitamura K, et al. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukaemia relapsed from complete remission induced by all-trans retinoic acid. Blood 90: 967–973, 1 Aug 1997
Ishibashi Y, Harada S, Ohkawara A. A short-term application test of Am-80 ointment in the clinical phase II studies. Rinsho Iyaku 11: 539–544, No. 3, 1995
Ishibashi Y, Harada S, Ohkawara A. Preliminary dose-finding study on Am-80 ointment in the clinical phase II studies. Rinsho Iyaku 11: 545–554, No. 3, 1995
Oikawa T, Okayasu I, Ashino H. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. European Journal of Pharmacology 249: 113–116, 2 Nov 1993
Algate DR, Atterson PR, Beard DJ. General pharmacology of new synthetic retinoid, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napththyl)carbamoyl] benzoic acid (Am-80) in experimental animals. Pharmacometrics 47: 451–463, May 1994
Kuwabara K, Matsumoto M, Koizumi K. Effect of Am-80, a synthetic retinoid, on collagen-induced arthritis in rats. Japanese Journal of Pharmacology 67 (Suppl. I): 291, 1995
Ishibashi Y, Harada S, Ohkawara A. Dose-finding study on Am-80 ointment in the clinical phase II studies. Rinsho Iyaku 11: 555–564, No. 3, 1995
Rights and permissions
About this article
Cite this article
Tamibarotene. Drugs R D 5, 359–362 (2004). https://doi.org/10.2165/00126839-200405060-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200405060-00010